OSR HOLDINGS INC (OSRH)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.28+136.05%
Close 2026-08-31 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OSRH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 1.8 | 2.9 | — | — | — | — | — |
| Total Revenues | 1.8 | 2.9 | — | — | — | — | — |
| Cost of Revenues | 1.2 | 2.3 | — | — | — | — | — |
| Gross Profit | 0.6 | 0.6 | — | — | — | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 17.5 | 18.9 | — | 1.8 | 0.0 | 0.0 | — |
| R&D Expenses | — | 0.3 | — | — | — | — | — |
| Operating Income | (16.9) | (18.3) | (3.5) | (1.8) | (0.0) | (0.0) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.5 | 0.0 | — | — | — | — |
| Interest & Investment Income | 0.1 | 0.1 | 1.5 | 2.8 | — | — | — |
| Other Non-Operating Income / Expenses | — | — | 1.4 | 2.8 | — | — | — |
| EBT, Incl. Unusual Items | (17.6) | (28.9) | (2.1) | 0.9 | — | — | — |
| Income Tax Expense | — | (1.8) | 0.3 | 0.5 | — | — | — |
| Net Income | |||||||
| Minority Interest | — | (9.0) | — | — | — | — | — |
| Net Income | (14.9) | (27.1) | (2.4) | 0.4 | (0.0) | (0.0) | — |
| Per Share | |||||||
| Basic EPS | — | (0.92) | (0.54) | 0.05 | (0.01) | — | — |
| Diluted EPS | — | (0.80) | (0.54) | 0.05 | (0.01) | — | — |
| Basic Weighted Avg Shares | — | 19.5 | 4.5 | 7.7 | 1.5 | — | — |
| Diluted Weighted Avg Shares | — | 22.6 | 4.5 | 7.7 | 1.5 | — | — |
| Supplemental | |||||||
| EBIT | (16.9) | (18.3) | (3.5) | (1.8) | (0.0) | (0.0) | — |
| Effective Tax Rate | — | — | — | 57.3% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.